Chips, EVs, and the New North American Factory

Episode Narrative

Chips, EVs, and the New North American Factory

In the late 20th century, the world stood on the precipice of a monumental shift. The connections between human ingenuity and technological advancement were becoming clearer, as the dawn of the genomic era began to unfold. This period, spanning from 1991 to 2003, was marked by groundbreaking initiatives that would lay the foundation for personalized medicine, revolutionizing the way we approach health. The Human Genome Project, an extraordinary collaborative effort, aimed to unlock the mysteries of human DNA, helping to shape new pathways in scientific research and medical treatment.

As the project came to fruition, it opened doors that had long been closed. Researchers unveiled targeted therapies that transformed lives, marking milestones in the treatment of diseases long deemed insurmountable. Notable among them were breakthroughs in therapies for breast cancer and chronic myeloid leukemia. The introduction of HER2 inhibitors, such as Herceptin, and agents like Gleevec, represented not just treatments but a promise of a new future in medicine. This was more than just science; it was a lifeline for countless patients and families struggling against the tide of illness.

As the 1990s progressed, another significant advance emerged: effective antiretroviral therapy for HIV was developed in 1995. This was a watershed moment in infectious disease treatment, transforming HIV from a death sentence into a manageable condition. As treatment narrowed the gap between life and mortality, it offered hope to millions, a beacon during a dark time. The shift was palpable, not just in medical circles, but in communities around the globe, as rates of transmission began to decline.

The year 1998 further highlighted advancements in medical science with the introduction of the first monoclonal antibody therapy aimed at preventing respiratory syncytial virus in at-risk infants. This innovation spoke volumes about the power of immunotherapy; it was a testament to how far medicine had come and how much further it could go in protecting the most vulnerable among us.

As we moved into the 21st century, the themes of innovation and resurgence became increasingly pronounced across North America. Enter the CHIPS Act. In the 2000s, this legislation served as a catalyst aimed at revitalizing semiconductor fabrication plants across the United States. The goal was clear: to decrease dependency on foreign chip manufacturing while bolstering domestic high-tech capacity. As technology became ensconced in every facet of life, from homes to automobiles, the need for secure and reliable semiconductor supply chains grew ever more urgent.

By the 2010s, the automotive landscape began to shift dramatically. Mexico positioned itself as a central manufacturing hub for electric vehicles, leveraging its existing automotive industry and trade agreements to weave itself into the burgeoning electric vehicle supply chain. This transition was more than mere economic maneuvering; it marked a transformation of values toward sustainability and innovation within the industry. A shift was underway, and it was powered by an understanding that the future of transportation must also consider the future of the planet.

Conversely, Canada stepped into the spotlight in the 2020s by heavily investing in battery plants specialized in lithium-ion production. The intent was not merely to compete in the North American clean energy transition but to set a precedent in energy independence and technological evolution. These efforts did not exist in isolation; they were part of a grand vision that encompassed the entire continent.

Simultaneously, the Lithium Triangle of South America, consisting of Chile, Argentina, and Bolivia, emerged as a global hotspot for lithium extraction. This region, rich in natural resources, was drawing the world's attention for its potential to fuel North American electric vehicle manufacturing. As countries experimented with new extraction technologies to minimize environmental impact, they stood at a crossroads, offering raw materials that could empower a cleaner, more sustainable energy future.

However, not all advancements in North America were marked by triumph. Between 2006 and 2018, the Fort Worth Basin in Texas experienced an unsettling surge in seismic activity. Linked to wastewater injection from oil and gas operations, the tremors highlighted the geotechnical and environmental challenges that often accompany energy production. Such events reminded society of the delicate balance between development and its ecological footprint.

The connection between technology and health surged forward as advanced neurotechnology breakthroughs emerged from the U.S. labs. By 2019, functional ultrasound brain-machine interfaces enabled novel ways to interact with technology, promising less invasive methods for controlling motion directions in primates. Such advancements hinted at an expansive future where human-machine synergy could redefine interaction within medical and technological realms.

As the world grappled with the shadows of the COVID-19 pandemic, a unique collaboration unfolded between the U.S. and Latin American countries. From 2020 to 2025, genomic surveillance capabilities for SARS-CoV-2 and other infectious diseases were expanded. This partnership was more than a reaction to a crisis; it was a testament to the necessity of unity in science. By combining resources and expertise, nations worked to build a robust infrastructure capable of withstanding future health challenges.

Simultaneously, scientific output from Latin America surged, compelling international collaboration in high-energy physics, cosmology, and biomedicine. Although disparities with North America persisted, the vigor and ambition within the region's research community pointed toward a brighter future, one where shared challenges would drive shared solutions.

The adaptability and resilience of North America in the face of change have remained striking. With bipartisan support and public backing, the U.S. continued its dominance in biomedical research throughout the 2020s. The development of cutting-edge therapies reflected more than advancements in medicine; they manifested a collective human endeavor to confront the most pressing health challenges with determination and creativity.

In 2024, the journal *Advanced Science* celebrated a decade of breakthroughs, heralding advancements in materials science and sustainability. This anniversary served as an important reminder of the intricate relationships between various disciplines, spanning continents and illuminating the interconnectedness of global scientific endeavor.

As we reflect on the evolution of the automotive industry from 1991 to 2025, a clear narrative emerges. The rise of electric vehicles coupled with innovations in battery production in Canada, expanded assembly in Mexico, and contributions from South America created a continent-wide ecosystem for manufacturing. This narrative illustrates not just progress but a well-orchestrated ballet of resources, ambition, and foresight.

Yet, amid these advancements, a darker shadow loomed in South America — the challenges surrounding biotechnological sovereignty. The COVID-19 pandemic exposed vulnerabilities in dependency on foreign technologies, underscoring the urgent need for systematic policies to bolster local capacities in health technologies. This lesson loomed large, reminding nations that true resilience often lies in autonomy and self-sufficiency.

Thus, as we stand at the crossroads of history and modernity, we envision a future shaped by the lessons learned across decades. The interactions between chips, vehicles, and the ambitious dreams of a new North American factory continue to unfold. What echoes do we hear as we navigate this terrain? Are they the sounds of progress, or are they a call to ensure that the future we build is not just technologically advanced but also equitable and sustainable for generations to come? The answers, it seems, lie not in the fabric of chips or vehicles alone, but in the values we uphold as we step into this new era.